Catalyst
Slingshot members are tracking this event:
Tesaro (TSRO) Plans to Report Phase 2 QUADRA Data in Q1 2018 Evaluating Niraparib in Ovarian Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
TSRO |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 24, 2018
Occurred Source:
http://ir.tesarobio.com/news-releases/news-release-details/tesaro-announces-positive-top-line-results-quadra-trial-zejular
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Quadra, Niraparib, Ovarian Cancer